Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer

Robert E. Reiter, Zhennen Gu, Tetsuro Watabe, George Thomas, Kinga Szigeti, Elizabeth Davis, Matthew Wahl, Sazuku Nisitani, Joyce Yamashiro, Michelle M. Le Beau, Massimo Loda, Owen N. Witte

Research output: Contribution to journalArticle

529 Citations (Scopus)

Abstract

The identification of cell surface antigens is critical to the development of new diagnostic and therapeutic modalities for the management of prostate cancer. Prostate stem cell antigen (PSCA) is a prostate-specific gene with 30% homology to stem cell antigen 2, a member of the Thy-1/Ly-6 family of glycosylphosphatidylinositol (GPI)-anchored cell surface antigens. PSCA encodes a 123-aa protein with an amino-terminal signal sequence, a carboxyl-terminal GPI-anchoring sequence, and multiple N-glycosylation sites. PSCA mRNA expression is prostate-specific in normal male tissues and is highly up-regulated in both androgen-dependent and -independent prostate cancer xenografts. In situ mRNA analysis localizes PSCA expression in normal prostate to the basal cell epithelium, the putative stem cell compartment of the prostate. There is moderate to strong PSCA expression in 111 of 126 (88%) prostate cancer specimens examined by in situ analysis, including high-grade prostatic intraepithelial neoplasia and androgen-dependent and androgen- independent tumors. Flow cytometric analysis demonstrates that PSCA is expressed predominantly on the cell surface and is anchored by a GPI linkage. Fluorescent in situ hybridization analysis localizes the PSCA gene to chromosome 8q24.2, a region of allelic gain in more than 80% of prostate cancers. A mouse homologue with 70% amino acid identity and similar genomic organization to human PSCA has also been identified. These results support PSCA as a target for prostate cancer diagnosis and therapy.

Original languageEnglish (US)
Pages (from-to)1735-1740
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume95
Issue number4
DOIs
StatePublished - Feb 17 1998
Externally publishedYes

Fingerprint

Surface Antigens
Prostate
Prostatic Neoplasms
Stem Cells
Antigens
Glycosylphosphatidylinositols
Androgens
Prostatic Intraepithelial Neoplasia
Messenger RNA
Protein Sorting Signals
Fluorescence In Situ Hybridization
Glycosylation
Heterografts
Genes
Epithelium
Chromosomes
Amino Acids

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Prostate stem cell antigen : A cell surface marker overexpressed in prostate cancer. / Reiter, Robert E.; Gu, Zhennen; Watabe, Tetsuro; Thomas, George; Szigeti, Kinga; Davis, Elizabeth; Wahl, Matthew; Nisitani, Sazuku; Yamashiro, Joyce; Le Beau, Michelle M.; Loda, Massimo; Witte, Owen N.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 95, No. 4, 17.02.1998, p. 1735-1740.

Research output: Contribution to journalArticle

Reiter, RE, Gu, Z, Watabe, T, Thomas, G, Szigeti, K, Davis, E, Wahl, M, Nisitani, S, Yamashiro, J, Le Beau, MM, Loda, M & Witte, ON 1998, 'Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer', Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 4, pp. 1735-1740. https://doi.org/10.1073/pnas.95.4.1735
Reiter, Robert E. ; Gu, Zhennen ; Watabe, Tetsuro ; Thomas, George ; Szigeti, Kinga ; Davis, Elizabeth ; Wahl, Matthew ; Nisitani, Sazuku ; Yamashiro, Joyce ; Le Beau, Michelle M. ; Loda, Massimo ; Witte, Owen N. / Prostate stem cell antigen : A cell surface marker overexpressed in prostate cancer. In: Proceedings of the National Academy of Sciences of the United States of America. 1998 ; Vol. 95, No. 4. pp. 1735-1740.
@article{a85bed4fffea4188b3b6142b7d301d22,
title = "Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer",
abstract = "The identification of cell surface antigens is critical to the development of new diagnostic and therapeutic modalities for the management of prostate cancer. Prostate stem cell antigen (PSCA) is a prostate-specific gene with 30{\%} homology to stem cell antigen 2, a member of the Thy-1/Ly-6 family of glycosylphosphatidylinositol (GPI)-anchored cell surface antigens. PSCA encodes a 123-aa protein with an amino-terminal signal sequence, a carboxyl-terminal GPI-anchoring sequence, and multiple N-glycosylation sites. PSCA mRNA expression is prostate-specific in normal male tissues and is highly up-regulated in both androgen-dependent and -independent prostate cancer xenografts. In situ mRNA analysis localizes PSCA expression in normal prostate to the basal cell epithelium, the putative stem cell compartment of the prostate. There is moderate to strong PSCA expression in 111 of 126 (88{\%}) prostate cancer specimens examined by in situ analysis, including high-grade prostatic intraepithelial neoplasia and androgen-dependent and androgen- independent tumors. Flow cytometric analysis demonstrates that PSCA is expressed predominantly on the cell surface and is anchored by a GPI linkage. Fluorescent in situ hybridization analysis localizes the PSCA gene to chromosome 8q24.2, a region of allelic gain in more than 80{\%} of prostate cancers. A mouse homologue with 70{\%} amino acid identity and similar genomic organization to human PSCA has also been identified. These results support PSCA as a target for prostate cancer diagnosis and therapy.",
author = "Reiter, {Robert E.} and Zhennen Gu and Tetsuro Watabe and George Thomas and Kinga Szigeti and Elizabeth Davis and Matthew Wahl and Sazuku Nisitani and Joyce Yamashiro and {Le Beau}, {Michelle M.} and Massimo Loda and Witte, {Owen N.}",
year = "1998",
month = "2",
day = "17",
doi = "10.1073/pnas.95.4.1735",
language = "English (US)",
volume = "95",
pages = "1735--1740",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "4",

}

TY - JOUR

T1 - Prostate stem cell antigen

T2 - A cell surface marker overexpressed in prostate cancer

AU - Reiter, Robert E.

AU - Gu, Zhennen

AU - Watabe, Tetsuro

AU - Thomas, George

AU - Szigeti, Kinga

AU - Davis, Elizabeth

AU - Wahl, Matthew

AU - Nisitani, Sazuku

AU - Yamashiro, Joyce

AU - Le Beau, Michelle M.

AU - Loda, Massimo

AU - Witte, Owen N.

PY - 1998/2/17

Y1 - 1998/2/17

N2 - The identification of cell surface antigens is critical to the development of new diagnostic and therapeutic modalities for the management of prostate cancer. Prostate stem cell antigen (PSCA) is a prostate-specific gene with 30% homology to stem cell antigen 2, a member of the Thy-1/Ly-6 family of glycosylphosphatidylinositol (GPI)-anchored cell surface antigens. PSCA encodes a 123-aa protein with an amino-terminal signal sequence, a carboxyl-terminal GPI-anchoring sequence, and multiple N-glycosylation sites. PSCA mRNA expression is prostate-specific in normal male tissues and is highly up-regulated in both androgen-dependent and -independent prostate cancer xenografts. In situ mRNA analysis localizes PSCA expression in normal prostate to the basal cell epithelium, the putative stem cell compartment of the prostate. There is moderate to strong PSCA expression in 111 of 126 (88%) prostate cancer specimens examined by in situ analysis, including high-grade prostatic intraepithelial neoplasia and androgen-dependent and androgen- independent tumors. Flow cytometric analysis demonstrates that PSCA is expressed predominantly on the cell surface and is anchored by a GPI linkage. Fluorescent in situ hybridization analysis localizes the PSCA gene to chromosome 8q24.2, a region of allelic gain in more than 80% of prostate cancers. A mouse homologue with 70% amino acid identity and similar genomic organization to human PSCA has also been identified. These results support PSCA as a target for prostate cancer diagnosis and therapy.

AB - The identification of cell surface antigens is critical to the development of new diagnostic and therapeutic modalities for the management of prostate cancer. Prostate stem cell antigen (PSCA) is a prostate-specific gene with 30% homology to stem cell antigen 2, a member of the Thy-1/Ly-6 family of glycosylphosphatidylinositol (GPI)-anchored cell surface antigens. PSCA encodes a 123-aa protein with an amino-terminal signal sequence, a carboxyl-terminal GPI-anchoring sequence, and multiple N-glycosylation sites. PSCA mRNA expression is prostate-specific in normal male tissues and is highly up-regulated in both androgen-dependent and -independent prostate cancer xenografts. In situ mRNA analysis localizes PSCA expression in normal prostate to the basal cell epithelium, the putative stem cell compartment of the prostate. There is moderate to strong PSCA expression in 111 of 126 (88%) prostate cancer specimens examined by in situ analysis, including high-grade prostatic intraepithelial neoplasia and androgen-dependent and androgen- independent tumors. Flow cytometric analysis demonstrates that PSCA is expressed predominantly on the cell surface and is anchored by a GPI linkage. Fluorescent in situ hybridization analysis localizes the PSCA gene to chromosome 8q24.2, a region of allelic gain in more than 80% of prostate cancers. A mouse homologue with 70% amino acid identity and similar genomic organization to human PSCA has also been identified. These results support PSCA as a target for prostate cancer diagnosis and therapy.

UR - http://www.scopus.com/inward/record.url?scp=13144250150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13144250150&partnerID=8YFLogxK

U2 - 10.1073/pnas.95.4.1735

DO - 10.1073/pnas.95.4.1735

M3 - Article

C2 - 9465086

AN - SCOPUS:13144250150

VL - 95

SP - 1735

EP - 1740

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 4

ER -